APA (7th ed.) Citation

A, A., M, M., M, J., T, P., TK, S., B, W., . . . M, B. (2026). STAR (stroma-tumor AI risk) assessment: Association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancer. BJC reports, 4(1), 4. https://doi.org/10.1038/s44276-026-00205-1

Chicago Style (17th ed.) Citation

A, Aggarwal, et al. "STAR (stroma-tumor AI Risk) Assessment: Association of AI-derived Tumor-stroma Proportion with Patient Survival Provides Added Prognostic Value Beyond KELIM in Epithelial Ovarian Cancer." BJC Reports 4, no. 1 (2026): 4. https://doi.org/10.1038/s44276-026-00205-1.

MLA (9th ed.) Citation

A, Aggarwal, et al. "STAR (stroma-tumor AI Risk) Assessment: Association of AI-derived Tumor-stroma Proportion with Patient Survival Provides Added Prognostic Value Beyond KELIM in Epithelial Ovarian Cancer." BJC Reports, vol. 4, no. 1, 2026, p. 4, https://doi.org/10.1038/s44276-026-00205-1.